I am a graduate student at the Helen Wills Neuroscience Institute at University of California Berkeley and a research associate at the California Pacific Medical Center Research Institute. My professional interests bridge neuroscience and psychopharmacology, and include mechanisms of hallucinations, toxicity of drugs of abuse, pharmacokinetics and dynamics of phenethylamines, and neural correlates of consciousness. Among other things, I am currently studying Hallucinogen Persisting Perception Disorder (HPPD).

If I weren't so busy being a scientist, I would be spinning some National Eye tunes, hanging out with my family (especially my radiant nephew and nieces), seeing some modern dance, collaborating on art projects, or continuing my quest to find the perfect font for my manuscripts.

Publications

• Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT: Psychological and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 162:396-405, 2002. (pdf)
• Vollenweider FX, Jones RT and Baggott MJ: Caveat emptor: Editors beware (letter). Neuropsychopharmacology 24:461-463, 2001.
• Baggott M, Heifets B, Jones RT, Mendelson J, Sferios E and Zehnder J: Chemical analysis of ecstasy pills. Jama 284:2190, 2000.
• Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J: Cardiovascular effects of 3,4-methylenedioxymethamphetamine A double-blind, placebo-controlled trial. Ann Intern Med 133:969-973, 2000. (pdf)
• Baggott M, Mendelson J and Jones R: More about parkinsonism after taking ecstasy. N Engl J Med 341:1400-1401, 1999.
• Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, Nath RP: Buprenorphine and naloxone combinations: The effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology 141:37-46, 1999.
• Baggott MJ; Mendelson J; Welm S; Ellis W; Jones RT: Reversal of ethanol-induced body sway by methamphetamine in standing humans (abstract). Problems of Drug Dependence 1997: Proceedings of the 59th Annual Scientific Meeting, NIDA Research Monograph, 1998, 178: 292.
• Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, and Baggott MJ: Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clin Pharmacol Ther 60:105-114, 1996.
• Baggott MJ: MDMA and FDA (letter). Herbalgram: Journal of the American Botanical Council and Herb Research Foundation, 1996, 38: 74.
• Richards JB, Baggott MJ, Sabol KE and Seiden LS: A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Res 627:254-260, 1993.

Reviews

• Baggott M: Preventing problems in ecstasy users: reduce use to reduce harm. J Psychoactive Drugs 34:145-162, 2002. (pdf)
• Baggott M and Mendelson J: Does MDMA cause brain damage?, in Ecstasy: the complete guide (Holland J ed) pp 110-145, Park Street Press, Rochester, VT, 2001.
• Bonson K and Baggott M: Emerging drugs of abuse, in Handbook of Neurotoxicology, Volume 2 (Massaro, EJ ed) pp. 223-257, Humana Press: Totowa, NJ, 2002.